Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Boston Scientific
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Short description|U.S.-based medical device company}} {{Multiple issues| {{Third-party|date=December 2018}} {{Advert|date=July 2024}} }} {{use mdy dates|date=August 2023}} {{Infobox company | name = Boston Scientific Corporation | logo = Boston Scientific Logo.svg | logo_size = 150px | type = [[Public company|Public]] | traded_as = {{ubl|{{NYSE|BSX}}|[[S&P 500]] component}} | ISIN = {{ISIN|sl=n|pl=y|US1011371077}} | founders = {{ubl|[[John Abele]]|[[Peter Nicholas (businessman)|Peter Nicholas]]}} | hq_location = [[Marlborough, Massachusetts]], U.S.<!--see coord below--> | key_people = {{unbulleted list|Michael F. Mahoney ([[Chairman]] and [[Chief executive officer|CEO]]) | Daniel Brennan ([[Chief financial officer|CFO]])}} | industry = [[Medical device]] | products = | revenue = {{nowrap|{{increase}} {{US$|16.75 billion|link=yes}} (2024){{Sfn|"Form 10K," December 31,|2024}} }} | operating_income = {{increase}} {{US$|2.603 billion}} (2024){{Sfn|"Form 10K," December 31,|2024}} | net_income = {{increase}} {{US$|1.853 billion}} (2024){{Sfn|"Form 10K," December 31,|2024}} | assets = {{increase}} {{US$|39.39 billion}} (2024){{Sfn|"Form 10K," December 31,|2024}} | equity = {{increase}} {{US$|21.77 billion}} (2024){{Sfn|"Form 10K," December 31,|2024}} | num_employees = 53,000{{Sfn|"Form 10K," December 31,|2024}} | num_employees_year = 2024 | foundation = {{start date and age|1979|6|29}} in [[Watertown, Massachusetts]] | website = {{URL|bostonscientific.com}} }} {{Coord|42|21|37.3|N|71|33|32.6|W|display=title}} '''Boston Scientific Corporation''' ('''BSC'''), headquartered in [[Marlborough, Massachusetts]] and incorporated in [[Delaware]],{{sfn|SEC Report|}} is an American [[biotechnology]] and [[biomedical engineering]] firm and multinational manufacturer of [[medical device]]s used in interventional [[Specialty (medicine)|medical specialties]], including [[interventional radiology]], [[interventional cardiology]], peripheral interventions, [[Neuromodulation (medicine)|neuromodulation]], neurovascular intervention, [[electrophysiology]], [[cardiac surgery]], [[vascular surgery]], [[endoscopy]], [[oncology]], [[urology]] and [[gynecology]]. Boston Scientific is widely known for the development of the Taxus [[Stent]], a [[drug-eluting stent]] which is used to open [[Vascular occlusion|clogged]] [[Artery|arteries]].{{Sfn|Wood, March 4,|2004}} With the full acquisition of [[Cameron Health]] in June 2012, the company also became notable for offering a minimally invasive [[implantable cardioverter-defibrillator]] (ICD) which they call the EMBLEM [[Subcutaneous Implantable Defibrillator (S-ICD)|subcutaneous implantable defibrillator (S-ICD)]].{{Sfn|Cameron Health, June 8,|2012}}{{Sfn|"EMBLEM SβISC System,"|2020}}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)